Initial evaluation of PET/CT with 18 F-FSU-880 targeting prostate-specific membrane antigen in prostate cancer patients.
Saga T, Nakamoto Y, Ishimori T, Inoue T, Shimizu Y, Kimura H, Akamatsu S, Goto T, Watanabe H, Kitaguchi K, Watanabe M, Ono M, Saji H, Ogawa O, Togashi K.
Saga T, et al. Among authors: shimizu y.
Cancer Sci. 2019 Feb;110(2):742-750. doi: 10.1111/cas.13911. Epub 2019 Jan 4.
Cancer Sci. 2019.
PMID: 30549183
Free PMC article.